Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.435    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.44
Spread: 0.01 (0.412%)
Market Cap: $8.03b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

1st Quarter Separate Results

11 May 2017 07:00

RNS Number : 7803E
Commercial Intnl Bank (Egypt) SAE
11 May 2017
 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/7803E_-2017-5-10.pdf

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

March 31st, 2017

FINANCIAL POSITION

As of March 31st, 2017

Amounts in EGP Thousands

Note

March 31, 2017

 

December 31, 2016

 

Assets

Cash and balances with central bank

15

15,101,163

10,522,040

Due from banks

16

65,449,817

58,011,034

Treasury bills and other governmental notes

17

39,956,034

39,177,184

Trading financial assets

18

2,209,221

2,445,134

Loans and advances to banks, net

19

69,384

159,651

Loans and advances to customers, net

20

86,670,859

85,991,914

Derivative financial instruments

21

95,242

269,269

Financial investments

- Available for sale

22

5,139,805

5,447,291

- Held to maturity

22

49,389,060

53,924,936

Investments in associates

23

10,500

10,500

Non current assets held for sale

42

239,875

428,011

Other assets

24

6,241,609

5,446,025

Intangible assets

41

466,579

499,131

Deferred tax assets (Liabilities)

32

195,918

181,308

Property, plant and equipment

25

1,402,583

1,338,629

Total assets

272,637,649

263,852,057

Liabilities and equity

Liabilities

Due to banks

26

2,598,068

3,008,996

Due to customers

27

239,730,858

231,965,312

Derivative financial instruments

21

163,896

331,091

Dividends Payable

576,933

-

Current tax liabilities

598,735

2,017,034

Other liabilities

29

5,204,188

3,579,330

Long term loans

28

155,218

160,243

Other provisions

30

1,603,192

1,514,057

Total liabilities

250,631,088

242,576,063

Equity

Issued and paid up capital

31

11,538,660

11,538,660

Reserves

34

8,261,895

3,443,319

Reserve for employee stock ownership plan (ESOP)

420,564

343,460

Total equity

20,221,119

15,325,439

Net profit for the period/year

1,785,442

5,950,555

Total equity and net profit for the period/ year

22,006,561

21,275,994

Total liabilities and equity

272,637,649

263,852,057

INCOME STATEMENT

As of March 31, 2017

Amounts in EGP Thousands

Note

March 31, 2017

 

March 31, 2016

 

Interest and similar income

6,376,570

4,178,859

Interest and similar expense

(3,593,103)

(1,910,574)

Net interest income

6

2,783,467

2,268,285

Fee and commission income

647,861

463,058

Fee and commission expense

(130,060)

(83,981)

Net fee and commission income

7

517,801

379,077

Dividend income

8

1,799

492

Net trading income

9

386,603

107,642

Profits on financial investments

22

323,473

91,474

Administrative expenses

10

(746,457)

(601,548)

Other operating (expenses) income

11

(357,997)

(161,400)

Goodwill impairment

41

-

(10,854)

Intangible assets amortization

41

(32,552)

(32,552)

Impairment charge for credit losses

12

(506,570)

(287,613)

Profit before income tax

2,369,567

1,753,003

Income tax expense

13

(598,735)

(482,726)

Deferred tax assets (Liabilities)

32 & 13

14,610

58,435

Net profit for the year

1,785,442

1,328,712

Earnings per share

14

Basic

1.37

1.02

Diluted

1.35

1.00

CASH FLOW STATEMENT

As of March 31, 2016

 

 

 

Amounts in EGP Thousands

 

March 31, 2017

March 31, 2016

Cash flow from operating activities

Profit before income tax

2,369,567

1,753,003

 

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

84,592

64,951

Impairment charge for credit losses

506,570

287,613

Other provisions charges

88,440

23,622

Trading financial investments revaluation differences

(49,057)

195,000

Available for sale and held to maturity investments exchange revaluation differences

16,596

(263,567)

Goodwill impairment

-

10,854

Intangible assets amortization

32,552

32,552

Financial investments impairment charge

(59,574)

19,481

Utilization of other provisions

(358)

(470)

Other provisions no longer used

(2,470)

(33,132)

Exchange differences of other provisions

3,523

62,934

Profits from selling property, plant and equipment

-

(164)

Profits from selling financial investments

53,608

(16,259)

Profits (losses) from selling associates

-

(84,934)

Shares based payments

77,104

48,661

Impairment (Released) charges of non current assets held for sale

(312,731)

-

 

Operating profits before changes in operating assets and liabilities

 

2,808,362

2,100,145

Net decrease (increase) in assets and liabilities

Due from banks

(6,369,580)

(5,624,857)

Treasury bills and other governmental notes

(1,278,538)

3,942,273

Trading financial assets

284,970

686,027

Derivative financial instruments

6,832

(87,486)

Loans and advances to banks and customers

(1,095,248)

(3,899,476)

Other assets

(739,325)

425,985

Non Current Assets Held for Sale

188,136

-

Due to banks

(410,928)

(971,815)

Due to customers

7,765,546

14,118,360

Income tax obligations paid

(2,017,034)

(1,949,694)

Other liabilities

1,624,858

1,592,521

Net cash provided from operating activities

768,051

10,331,983

Cash flow from investing activities

Proceeds from selling subsidiary and associates

-

159,989

Payment for purchases of property, plant, equipment and branches constructions

(204,805)

(174,558)

Proceeds from redemption of held to maturity financial investments

7,111,107

1,311

Payment for purchases of held to maturity financial investments

(2,575,231)

-

Payment for purchases of available for sale financial investments

(153,395)

(129,845)

Proceeds from selling available for sale financial investments

480,343

2,332,077

Proceeds from selling non current assets held for sale

500,867

-

Net cash used in investing activities

5,158,886

2,188,974

Cash flow from financing activities

Increase (decrease) in long term loans

(5,025)

(7,094)

Dividend paid

(773,274)

(1,463,450)

Net cash used in financing activities

(778,299)

(1,470,544)

 

Net increase (decrease) in cash and cash equivalent during the period

5,148,638

11,050,413

Beginning balance of cash and cash equivalent

61,518,700

22,433,117

Cash and cash equivalent at the end of the period

66,667,338

33,483,530

Cash and cash equivalent comprise:

Cash and balances with central bank

15,101,163

16,409,342

Due from banks

65,449,817

31,110,134

Treasury bills and other governmental notes

39,956,034

18,194,950

Obligatory reserve balance with CBE

(10,066,100)

(13,893,058)

Due from banks with maturities more than three months

(4,307,610)

(149,940)

Treasury bills with maturity more than three months

(39,465,966)

(18,187,898)

Total cash and cash equivalent

66,667,338

33,483,530

 

Separate statement of changes in shareholders' equity for the period ended March 31, 2016

 

Mar. 31, 2016

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the period

Reserve for employee stock ownership plan

Total

 

EGP Thousands

 

Beginning balance

11,470,603

803,355

1,518,525

30,214

(2,202,463)

2,513

4,640,718

248,148

16,511,613

 

Transferred to reserves

-

232,008

2,944,190

564

-

-

(3,176,762)

-

-

 

Dividend paid

-

-

-

-

-

-

(1,463,450)

-

(1,463,450)

 

Net profit for the period

-

-

-

-

-

-

1,328,712

-

1,328,712

 

Net unrealised gain/(loss) on AFS

-

-

-

-

(1,873,055)

-

-

-

(1,873,055)

 

Transferred (from) to bank risk reserve

-

-

-

-

-

506

(506)

-

-

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

48,661

48,661

 

Balance at the end of the period

11,470,603

1,035,363

4,462,715

30,778

(4,075,518)

3,019

1,328,712

296,809

14,552,481

 

 

Separate statement of changes in shareholders' equity for the period ended March 31, 2017

 

Mar. 31, 2017

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the period

Reserve for employee stock ownership plan

Total

 

EGP Thousands

 

Beginning balance

11,538,660

1,035,363

4,554,403

30,778

(2,180,244)

3,019

5,950,555

343,460

21,275,994

 

Transferred to reserves

-

297,444

4,300,607

1,682

-

-

(4,599,733)

-

-

 

Dividend paid

-

-

-

-

-

-

(1,350,207)

-

(1,350,207)

 

Net profit for the period

-

-

-

-

-

-

1,785,442

-

1,785,442

 

Net unrealised gain/(loss) on AFS

-

-

-

-

218,228

-

-

-

218,228

 

Transferred (from) to bank risk reserve

-

-

-

-

-

615

(615)

-

-

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

77,104

77,104

 

Balance at the end of the period

11,538,660

1,332,807

8,855,010

32,460

(1,962,016)

3,634

1,785,442

420,564

22,006,561

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFFMGMKKGLGNZM
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.